K. Grosch

发表

Effect of cyclosporine coadministration on the pharmacokinetics of eltrombopag in healthy volunteers

T. Ouatas, V. Aslanis, Jianping Zhang, 2018, Cancer Chemotherapy and Pharmacology.

Everolimus dosing recommendations for tuberous sclerosis complex–associated refractory seizures

J. French, M. Kohrman, C. Brandt, 2018, Epilepsia.

Relationship between everolimus exposure and safety and efficacy: meta-analysis of clinical trials in oncology.

A. Ravaud, D. Sellami, W. Cheung, 2014, European journal of cancer.

Hybridization between two insectivorous bird species and the effect on prey-handling efficiency

K. Grosch, 2004, Evolutionary Ecology.

Population Pharmacokinetics and Pharmacodynamics of Crizanlizumab in Healthy Subjects and Patients with Sickle Cell Disease

C. Tanaka, S. Sy, K. Grosch, 2022, Clinical Pharmacokinetics.

Evaluation of drug–drug interactions between midostaurin and strong CYP3A4 inhibitors in patients with FLT-3-mutated acute myeloid leukemia (AML)

T. Ouatas, K. Grosch, R. Sechaud, 2022, Cancer Chemotherapy and Pharmacology.

Effect of everolimus on the pharmacokinetics of octreotide long‐acting repeatable in patients with advanced neuroendocrine tumors: An analysis of the randomized phase III RADIANT‐2 trial

C. Becerra, W. Cheung, J. Hasskarl, 2017, Clinical pharmacology and therapeutics.

Hybridization between redstart Phoenicurus phoenicurus and black redstart P. ochruros, and the effect on habitat exploitation

K. Grosch, 2004 .

Model‐Informed Drug Development for Everolimus Dosing Selection in Pediatric Infant Patients

T. Heimbach, N. Coello, F. Combes, 2020, CPT: pharmacometrics & systems pharmacology.

Modelling PK/QT relationships from Phase I dose‐escalation trials for drug combinations and developing quantitative risk assessments of clinically relevant QT prolongations

Jixian Wang, K. Grosch, Karen Sinclair, 2016, Pharmaceutical statistics.